J. Jay Lobell

J. Jay Lobell (board member) discloses dealings in 5 companies, chiefly Fortress Biotech, Inc., Chem RX Corp and Pardes Biosciences, Inc. Over a trading history stretching from 19 April 2006 to 1 January 2026, the count stands at 31 filings.

On the market, this insider has only ever bought: 5 purchases, €458k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 19 share grants.

In size, the median ticket on the buying side is €58k.

The latest filing, published on 5 January 2026, reports a share grant in Fortress Biotech, Inc. The latest purchase dates back some time: it was published 1,348 days ago, on 14 February 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.